Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression. 2017

Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku Kumamoto, Japan.

The overexpression of IL-12 family cytokines is implicated in the pathogenesis of SSc, but their exact role is still unclear. The aim of this study was to investigate the regulation of extracellular matrix expression by IL-23 and its contribution to the phenotype of SSc. The mRNA expression was determined by PCR array and real-time PCR. The expression levels of proteins were determined by immunoblotting and immunohistochemical staining. The effect of IL-23 on dermal fibrosis in vivo was examined in a mouse model of SSc induced by bleomycin injection. Among the IL-12 family members, IL-23 decreased expression of type I collagen protein in cultured normal dermal fibroblasts. We found that miR-4458 and miR-18a mediated the reduction of collagen expression by IL-23. On the contrary, IL-23 up-regulated type I collagen expression in SSc fibroblasts. The paradoxical effects of IL-23 in SSc fibroblasts were also mediated by the balance between miR-4458 and miR-18a expression. Moreover, we revealed that injection of IL-23 into the mouse skin accelerated skin fibrosis. This is the first study to report that the balance of two miRNAs is involved in the collagen dysregulation in SSc fibroblasts. Clarification of the regulatory mechanism of tissue fibrosis by IL-23 in SSc skin may lead to a better understanding of this disease and new therapeutic approaches.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005109 Extracellular Matrix A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere. Matrix, Extracellular,Extracellular Matrices,Matrices, Extracellular
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
April 2012, Journal of immunology (Baltimore, Md. : 1950),
Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
February 1998, The Journal of rheumatology,
Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
September 2016, Fertility and sterility,
Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
April 2012, Journal of immunology (Baltimore, Md. : 1950),
Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
April 2018, Journal of dermatological science,
Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
July 1997, Arthritis and rheumatism,
Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
November 2023, Intractable & rare diseases research,
Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
May 1988, The Journal of investigative dermatology,
Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
December 2008, Nature,
Wakana Nakayama, and Masatoshi Jinnin, and Yukiko Tomizawa, and Kayo Nakamura, and Hideo Kudo, and Kuniko Inoue, and Katsunari Makino, and Noritoshi Honda, and Ikko Kajihara, and Satoshi Fukushima, and Hironobu Ihn
February 1984, Biochimica et biophysica acta,
Copied contents to your clipboard!